EUVIMEDEUVIMED entdecken
Leserbrief

In Reply to Pomeroy et al

Jarad M Martin, Roel J H M Steenbakkers, David Schlect

International Journal of Radiation Oncology*Biology*Physics · 2026-08 · 125 (5) · 1565-1566

DOI: 10.1016/j.ijrobp.2026.04.083 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-08. Verfasst von Jarad M Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: GenesisCare Gateshead, Radiation Oncology, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia. Electronic address: jarad.martin@…. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • GenesisCare Gateshead, Radiation Oncology, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia. Electronic address: jarad.martin@health.nsw.gov.au.
  • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • GenesisCare, Brisbane, Queensland, Australia.

Zitieren

APA

Martin, J. M., Steenbakkers, R. J. H. M., & Schlect, D. (2026). In Reply to Pomeroy et al. International Journal of Radiation Oncology*Biology*Physics, 125(5), 1565-1566. https://doi.org/10.1016/j.ijrobp.2026.04.083

Vancouver

Martin JM, Steenbakkers RJHM, Schlect D. In Reply to Pomeroy et al. International Journal of Radiation Oncology*Biology*Physics. 2026;125(5):1565-1566. doi:10.1016/j.ijrobp.2026.04.083

BibTeX
@article{Martin2026,
  author = {Martin, Jarad M and Steenbakkers, Roel J H M and Schlect, David},
  title = {In Reply to Pomeroy et al},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {125},
  number = {5},
  pages = {1565--1566},
  doi = {10.1016/j.ijrobp.2026.04.083}
}
Kostenlos starten →